(Q41312469)

29 September 2017

1 reference

title

Autoimmunity to ion-channels and other proteins in paraneoplastic disorders (English)

1 reference

29 September 2017

Lang B

1

1 reference

PubMed ID

8994868

29 September 2017

Vincent A

series ordinal

2

1 reference

29 September 2017

1 December 1996

1 reference

Current Opinion in Immunology

29 September 2017

1 reference

29 September 2017

8

1 reference

29 September 2017

865-871

1 reference

29 September 2017

6

1 reference

Clinical enigmas of paraneoplastic neurologic disorders

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Immune diagnosis of paraneoplastic neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Aetiological factors in development of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Acetylcholine receptor subunit gene expression in thymic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Thymomas express epitopes shared by the ryanodine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

A clinical triad to diagnose paraneoplastic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Limbic encephalitis and immunological perturbations in two patients with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Neurological sequelae of the dancing eye syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The expression of a neuronal nuclear antigen (Ri) recognized by the human anti-Ri autoantibody in the developing rat nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Anti-tumour therapy in paraneoplastic neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

The role of autoimmunity to glutamate receptors in neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980017-3

7 January 2021

10.1016/S0952-7915(96)80017-3

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

8994868